Author

H. Irjala

University of TurkuORCID 0000-0003-3054-4677Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

H. Irjala1 paper

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Antti A. MäkitieiD· 1 shared Fabian KrautgasseriD· 1 shared Fabien BertillotiD· 1 shared Gautier FollainiD· 1 shared Giorgio ScitaiD· 1 shared Hellyeh HamidiiD· 1 shared Hind AbdoiD· 1 shared Jaana HagströmiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Antti A. MäkitieORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell BiologyNature MaterialsPeer-reviewedFeb 20, 2026

Restoring mechanophenotype reverts malignant properties of ECM-enriched vocal fold cancer

Jasmin Kaivola, Karolina Punovuori, Megan R. Chastney…·Johanna Ivaska

This study shows that restoring mechanophenotype or targeting YAP/TAZ can reverse malignant properties of vocal fold cancer by reducing nuclear YAP and β-catenin levels.

6 citationstop 3%

humanproteomics

𝕏 PostBluesky